Scholarlink

Purpose <p>We characterized the association between photon radiation dose (&lt; 59.4 versus ≥ 59.4&#xa0;Gy) and outcomes in intracranial ependymoma. We also examined factors associated with survival after relapse.</p> Methods <p>This multi-institutional retrospective study included patients age ≤ 21 years who received postoperative definitive-intent photon radiotherapy for posterior fossa ependymoma between 1997 and 2021. Clinical characteristics were obtained from medical records. Five-year overall (OS) and progression-free (PFS) survival were estimated using the Kaplan-Meier method. Factors associated with progression after radiotherapy, including dose &lt; 59.4 versus ≥ 59.4&#xa0;Gy, were analyzed using Fine and Gray’s proportional subhazards model. Factors associated with post-relapse survival were explored using the Cox proportional-hazards model.</p> Results <p>We identified 45 patients meeting inclusion criteria; 48.9% received ≥ 59.4&#xa0;Gy. There was no difference in 5-year OS or PFS between those who received &lt; 59.4&#xa0;Gy versus ≥ 59.4 (OS 49.0% vs. 82.9%, <i>p</i> = 0.11; PFS 36.4% vs. 63.9%, <i>p</i> = 0.08); however, there was a trend towards worse 5-year OS and PFS among patients with grade 2 ependymoma who received &lt; 59.4&#xa0;Gy (OS 48.8% vs. 88.9%, <i>p</i> = 0.06, PFS 40.0% vs. 83.1%, <i>p</i> = 0.08). Only age &gt; 4 years at diagnosis (subdistribution hazard ratio [SHR]: 0.40, <i>p</i> = 0.03) was associated lower risk of progression. Following radiotherapy, 24 patients relapsed. Receipt of salvage systemic therapy was associated with worse post-relapse OS on multivariable analysis (HR = 2.84, <i>p</i> = 0.04).</p> Conclusion <p>Underlying biological factors such as age and molecular subtype may hold greater prognostic significance than radiation dose in pediatric ependymoma. Regardless, recurrences are common and outcomes remain poor. Further research into optimal management of relapsed disease is critical.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月25日

查看全文
  • Kevin X. Liu,
  • Mia Salans,
  • Teresa P. Easwaran,
  • Christina Phuong,
  • Kee Kiat Yeo,
  • Hesham Elhalawani,
  • Paul J. Catalano,
  • Kathryn Dusenbery,
  • Karen J. Marcus,
  • Stephanie A. Terezakis,
  • Daphne A. Haas-Kogan,
  • Steve E. Braunstein

摘要

Purpose

We characterized the association between photon radiation dose (< 59.4 versus ≥ 59.4 Gy) and outcomes in intracranial ependymoma. We also examined factors associated with survival after relapse.

Methods

This multi-institutional retrospective study included patients age ≤ 21 years who received postoperative definitive-intent photon radiotherapy for posterior fossa ependymoma between 1997 and 2021. Clinical characteristics were obtained from medical records. Five-year overall (OS) and progression-free (PFS) survival were estimated using the Kaplan-Meier method. Factors associated with progression after radiotherapy, including dose < 59.4 versus ≥ 59.4 Gy, were analyzed using Fine and Gray’s proportional subhazards model. Factors associated with post-relapse survival were explored using the Cox proportional-hazards model.

Results

We identified 45 patients meeting inclusion criteria; 48.9% received ≥ 59.4 Gy. There was no difference in 5-year OS or PFS between those who received < 59.4 Gy versus ≥ 59.4 (OS 49.0% vs. 82.9%, p = 0.11; PFS 36.4% vs. 63.9%, p = 0.08); however, there was a trend towards worse 5-year OS and PFS among patients with grade 2 ependymoma who received < 59.4 Gy (OS 48.8% vs. 88.9%, p = 0.06, PFS 40.0% vs. 83.1%, p = 0.08). Only age > 4 years at diagnosis (subdistribution hazard ratio [SHR]: 0.40, p = 0.03) was associated lower risk of progression. Following radiotherapy, 24 patients relapsed. Receipt of salvage systemic therapy was associated with worse post-relapse OS on multivariable analysis (HR = 2.84, p = 0.04).

Conclusion

Underlying biological factors such as age and molecular subtype may hold greater prognostic significance than radiation dose in pediatric ependymoma. Regardless, recurrences are common and outcomes remain poor. Further research into optimal management of relapsed disease is critical.